Malulife 200 tablet is indicated for treatment of adult patients with COVID-19 with Spo2 >93% and who have high risk of progression of disease including hospitalization or death. It is recommended in patients require immediate hospitalization due to COVID-19.
Reviews
There are no reviews yet.